JP Morgan Chase’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.9M | Sell |
177,858
-9,087
| -5% | -$117K | ﹤0.01% | 3904 |
|
|
2026
Q1 | $1.47M | Sell |
186,945
-16,561
| -8% | -$150K | ﹤0.01% | 4320 |
|
|
2025
Q4 | $1.95M | Sell |
203,506
-12,995
| -6% | -$123K | ﹤0.01% | 4088 |
|
|
2025
Q3 | $2.05M | Sell |
216,501
-23,531
| -10% | -$198K | ﹤0.01% | 4063 |
|
|
2025
Q2 | $1.79M | Sell |
240,032
-15,644
| -6% | -$97.1K | ﹤0.01% | 3991 |
|
|
2025
Q1 | $1.55M | Sell |
255,676
-82,639
| -24% | -$572K | ﹤0.01% | 4045 |
|
|
2024
Q4 | $2.63M | Buy |
338,315
+33,078
| +11% | +$247K | ﹤0.01% | 3939 |
|
|
2024
Q3 | $2.48M | Buy |
305,237
+285,726
| +1,464% | +$2.34M | ﹤0.01% | 3830 |
|
|
2024
Q2 | $135K | Sell |
19,511
-29,288
| -60% | -$394K | ﹤0.01% | 5369 |
|
|
2024
Q1 | $864K | Buy |
48,799
+19,574
| +67% | +$310K | ﹤0.01% | 4451 |
|
|
2023
Q4 | $453K | Sell |
29,225
-27,012
| -48% | -$353K | ﹤0.01% | 4861 |
|
|
2023
Q3 | $771K | Sell |
56,237
-7,811
| -12% | -$115K | ﹤0.01% | 4241 |
|
|
2023
Q2 | $1.1M | Buy |
64,048
+4,137
| +7% | +$84.6K | ﹤0.01% | 3985 |
|
|
2023
Q1 | $1.44M | Buy |
59,911
+10,933
| +22% | +$238K | ﹤0.01% | 3784 |
|
|
2022
Q4 | $850K | Buy |
48,978
+4,666
| +11% | +$98.3K | ﹤0.01% | 4163 |
|
|
2022
Q3 | $1.08M | Sell |
44,312
-237
| -0.5% | -$8.16K | ﹤0.01% | 3934 |
|
|
2022
Q2 | $1.38M | Buy |
44,549
+11,320
| +34% | +$301K | ﹤0.01% | 3847 |
|
|
2022
Q1 | $1.16M | Buy |
33,229
+5,398
| +19% | +$204K | ﹤0.01% | 4154 |
|
|
2021
Q4 | $1.65M | Buy |
27,831
+1,840
| +7% | +$127K | ﹤0.01% | 4004 |
|
|
2021
Q3 | $1.73M | Sell |
25,991
-5,271
| -17% | -$325K | ﹤0.01% | 3902 |
|
|
2021
Q2 | $1.97M | Sell |
31,262
-25,674
| -45% | -$1.45M | ﹤0.01% | 3800 |
|
|
2021
Q1 | $2.96M | Buy |
56,936
+39,140
| +220% | +$2.38M | ﹤0.01% | 3407 |
|
|
2020
Q4 | $781K | Sell |
17,796
-214,347
| -92% | -$10.2M | ﹤0.01% | 4106 |
|
|
2020
Q3 | $11.4M | Buy |
232,143
+47,916
| +26% | +$1.94M | ﹤0.01% | 1937 |
|
|
2020
Q2 | $5.57M | Buy |
184,227
+60,362
| +49% | +$1.34M | ﹤0.01% | 2381 |
|
|
2020
Q1 | $2.12M | Buy |
123,865
+59,008
| +91% | +$1.03M | ﹤0.01% | 2931 |
|
|
2019
Q4 | $1.07M | Buy |
64,857
+44,292
| +215% | +$659K | ﹤0.01% | 3807 |
|
|
2019
Q3 | $336K | Buy |
20,565
+10,595
| +106% | +$212K | ﹤0.01% | 4366 |
|
|
2019
Q2 | $179K | Buy |
9,970
+3,334
| +50% | +$52.9K | ﹤0.01% | 4705 |
|
|
2019
Q1 | $86K | Sell |
6,636
-70,497
| -91% | -$766K | ﹤0.01% | 4937 |
|
|
2018
Q4 | $851K | Sell |
77,133
-139,390
| -64% | -$1.52M | ﹤0.01% | 3844 |
|
|
2018
Q3 | $2.77M | Buy |
216,523
+57,154
| +36% | +$816K | ﹤0.01% | 3225 |
|
|
2018
Q2 | $2.52M | Buy |
+159,369
| New | +$1.7M | ﹤0.01% | 3235 |
|
Other funds holding CYRX
CCM
FAM
MCO
JP Morgan Chase's CYRX Position: Q2 2026 in Review
JP Morgan Chase reduced its CryoPort (CYRX) stake by 4.9% in Q2 2026, selling an estimated $117K and leaving 177,858 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3904.
JP Morgan Chase first reported a position in CYRX in Q2 2018 and has held it in 33 quarters since. The position peaked at $11.4M in Q3 2020. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.
- JP Morgan Chase held 177,858 shares of CryoPort worth $2.9M as of Q2 2026.
- JP Morgan Chase sold 9,087 CryoPort shares in Q2 2026, an estimated $117K.
- CryoPort made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3904 holding.
- JP Morgan Chase first reported a position in CryoPort in Q2 2018 and has held it in 33 quarters since.
- JP Morgan Chase's CryoPort position peaked at $11.4M in Q3 2020.
- 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.